Corona del Mar, California – Integrated Oncology Network, LLC (“ION”) today announced that it is partnering with Premier Physicians of New York, PLLC, a multispecialty oncologic group practice, and has acquired a minority equity interest in New York City First Land Partners, LLC, owners of: (i) Eastside Radiation Oncology Management, LLC, who provides management services and technology to Eastside Radiation Oncology, (ii) Tribeca Radiation Oncology Management, LLC, who provides management services and technology to Tribeca Radiation Oncology, and (iii) Manhattan Medical Development, LLC, who is developing a radiation center in midtown Manhattan.
“We are excited to partner with Drs. Tony Berson, Roberto Lipsztein, Tracy Ng and Richard Stock in New York” said Dr. Shyam Paryani, Managing Partner of New York First Land Partners and Director of Florida Radiation Oncology Group (FROG). “We will provide Comprehensive Cancer Care that is both compassionate and convenient in multiple locations in Manhattan.”
“This association will continue to enable us to provide cancer care in an outpatient setting for the downtown and Chinatown community” said Tracy Ng, M.D., Medical Director of Tribeca Radiation Oncology
Dr. Roberto Lipsztein Medical Director at Eastside Radiation Oncology stated, “The association with FROG and ION will allow us to enhance the state of art cancer care we have provided at each of our facilities”.
“We are privileged and excited to have the opportunity to provide technical and management expertise to this group of quality physicians.” said Jeffrey Goffman, CEO. “The structure of Premier Physicians is consistent with the goals of other healthcare providers that have formed accountable care organizations in an effort to provide quality medical services at a more efficient cost.”
Please visit our web sites for more information:
www.eastsideradiation.com
www.tribecaradiation.com
www.frogdocs.com
About ION
ION is a radiation oncology management and cancer center development company that provides oncology solutions for and minority investments in physician practices and hospitals that seek strategic, financial, and management expertise. ION provides solutions for the formation of integrated oncology groups and other compliant physician models, development for cancer centers, financing, and management services with expertise in radiation oncology operations, billing and collection, accounting, compliance, IT, M&A, physics and dosimetry, and other administrative services. ION provides liquidity for physician and hospital owners as it invests as a minority partner in radiation oncology centers with both physicians and hospitals. ION’s senior management team has over 100 years of combined health care expertise, including working as a trusted resource with several of the most prestigious oncology groups and hospital systems in the country. ION is the exclusive oncology center development partner to Philips Healthcare. ION currently has partnerships with 17 radiation cancer centers, including those affiliated with ION’s subsidiaries: SightLine Health, LLC, Prologics, LLC and Vicura Oncology, LLC.
ION is a privately held company whose shareholders include a small group of strategic investors, including Capricorn Investment Group and Comvest Group,and additionally, Madison Capital Funding as a debt partner.
For more information on ION, please visit our web site at www.ion-llc.com.
[eltdf_separator class_name=”” type=”full-width” position=”center” color=”#666666″ border_style=”dashed” width=”” thickness=”1″ top_margin=”20″ bottom_margin=”20″]About Capricorn Investment Group
Capricorn Investment Group is a private, independent investment firm designed to be an ideal partner for clients desiring a global portfolio driven by consistent returns and underpinned by a principled philosophy. Capricorn currently manages approximately $5 billion through various investment strategies, which cover a range of areas, from long term, diversified global growth investment strategies, venture capital and private equity, credit strategies, and “clean and green” growth capital. Capricorn’s investment philosophy is grounded in a strong fundamentals focused investment model, comprehensive research on long term, global mega-themes, such as energy, agriculture, transportation, consumer, health and wellness, technology, and consideration of business smart sustainability principles.
[eltdf_separator class_name=”” type=”full-width” position=”center” color=”#666666″ border_style=”dashed” width=”” thickness=”1″ top_margin=”20″ bottom_margin=”20″]About Comvest Group
The Comvest Group is a leading private investment firm focused on providing debt and equity capital to lower middle-market companies. Our firm includes seasoned, senior level operating executives at all levels who partner with managers and owners of companies to grow businesses and create long-term value. Since 1988, Comvest has invested more than $2 billion of capital in over 200 public and private companies. For more information, please visit www.comvest.com.
[eltdf_separator class_name=”” type=”full-width” position=”center” color=”#666666″ border_style=”dashed” width=”” thickness=”1″ top_margin=”20″ bottom_margin=”20″]Forward-Looking Statements
Statements in this Press Release that are not historical facts constitute “forward-looking statements.” Any statements contained herein which are not historical facts or which contain the words “anticipate,” “believe,” “continue,” “estimate,” “expect,” “intend,” “may,” “should,” and similar expressions are intended to identify forward-looking statements. Such statements reflect the current view of ION with respect to future events and are subject to certain risks, uncertainties and assumptions, including, but not limited to, the risk that ION may not be able to implement its growth strategy in the intended manner, including the ability to identify, finance, complete joint venture opportunities, risks regarding currently unforeseen competitive pressures and risks affecting ION’s industry, such as increased regulatory compliance and changes in regulatory requirements, changes in payor reimbursement levels. Should one or more of those risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described herein.
